IDIA.SW Gross Margin

The Gross Margin of Idorsia Ltd (IDIA.SW) is 68.07%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

IDIA.SW Gross Margin - Historical Value

Date	Value
2024-12-31	68.07%
2023-12-31	95.31%
2022-12-31	93.55%

IDIA.SW Gross Margin - Peers Comparison

Ticker	Name	Value
ACIU	AC Immune SA	7775.20%
HNSA.ST	Hansa Biopharma AB	51.23%
ORPHA.CO	Orphazyme A/S	7775.20%
PHM.MC	Pharma Mar SA	95.32%
VVY.AS	Vivoryon Therapeutics NV	85.42%
ZEAL.CO	Zealand Pharma A/S	87.44%
CANTA.ST	Cantargia AB	7775.20%
MOR.DE	MorphoSys AG	78.62%
SNG.L	Synairgen PLC	68.75%
VECT	VectivBio Holding AG	7775.20%
AVCT.L	Avacta Group PLC	48.37%
BGBIO.OL	Bergenbio ASA	100.00%
GLPG.AS	Galapagos NV	76.10%
OBSV	Obseva SA	7775.20%
OXB.L	Oxford Biomedica PLC	41.17%
ALCLS.PA	Cellectis SA	6.96%
CRSP	CRISPR Therapeutics AG	7775.20%
GNS.L	Genus PLC	36.68%
MOLN.SW	Molecular Partners AG	99.80%
SIGHT.PA	Gensight Biologics SA	188.37%
SLN.L	Silence Therapeutics PLC	3133.78%
ADCT	ADC Therapeutics SA	91.60%
BSLN.SW	Basilea Pharmaceutica AG Allschwil	81.45%
NANO.PA	Nanobiotix SA	100.00%
RLF.SW	Relief Therapeutics Holding SA	69.41%
ALBPS.PA	Biophytis SA	7775.20%
FYB.DE	Formycon AG	20.25%
IVACC.ST	Intervacc AB	-29.92%
MXCT.L	MaxCyte Inc	8942.64%
ABVX.PA	Abivax SA	-19700.00%
GNRO.PA	Geneuro SA	7775.20%
IPH.PA	Innate Pharma SA	94.50%
IVA.PA	Inventiva SA	146.31%